For research use only. Not for therapeutic Use.
TM-25659(CAT: I019606) serves as a multifaceted transcriptional co-activator with a PDZ-binding motif (TAZ) modulator. Its distinctive mode of action enables it to influence TAZ-related cellular processes, potentially offering therapeutic avenues for conditions related to bone health and metabolism. Notably, TM-25659 exhibits promising anti-osteoporotic effects by potentially enhancing bone density and strength. Additionally, its anti-obesity activities suggest a capacity to regulate adipose tissue and metabolic pathways, thereby contributing to potential interventions in obesity management.
| Catalog Number | I019606 |
| CAS Number | 260553-97-7 |
| Molecular Formula | C₃₀H₂₈N₈ |
| Purity | ≥95% |
| Reference | [1]. Jang EJ, et al. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ. Br J Pharmacol. 2012 Mar;165(5):1584-94. |
